Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas A Prohaska

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
The New England Journal of Medicine|April 8, 2024
Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular RiskBrian A Bergmark, Nicholas A Marston, Thomas A Prohaska, et al.
American Heart Journal|March 13, 2025
Olezarsen in patients with hypertriglyceridemia at high cardiovascular risk: Rationale and design of the Essence-TIMI 73b trialBrian A Bergmark, Nicholas A Marston, Thomas A Prohaska, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 13, 2016
Protective Role for B-1b B Cells and IgM in Obesity-Associated Inflammation, Glucose Intolerance, and Insulin ResistanceDaniel B Harmon, Prasad Srikakulapu, Jennifer L Kaplan, et al.
The New England Journal of Medicine|September 1, 2025
Targeting <i>APOC3</i> with Olezarsen in Moderate HypertriglyceridemiaBrian A Bergmark, Nicholas A Marston, Thomas A Prohaska, et al.
Nature|June 8, 2018
Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic miceXuchu Que, Ming-Yow Hung, Calvin Yeang, et al.
Nature|July 18, 2018
Publisher Correction: Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic miceXuchu Que, Ming-Yow Hung, Calvin Yeang, et al.
Circulation|March 30, 2026
Effect of APOC3 Inhibition with Olezarsen on Coronary Atherosclerosis: Essence-TIMI 73b Imaging StudyNicholas A Marston, Brian A Bergmark, Thomas A Prohaska, et al.
Molecular Cell|September 26, 2023
RANK ligand converts the NCoR/HDAC3 co-repressor to a PGC1β- and RNA-dependent co-activator of osteoclast gene expressionYohei Abe, Eric R Kofman, Maria Almeida, et al.
Immunity|March 21, 2025
Particle uptake by macrophages triggers bifurcated transcriptional pathways that differentially regulate inflammation and lysosomal gene expressionIsidoro Cobo, Jessica Murillo-Saich, Mohnish Alishala, et al.
The New England Journal of Medicine|November 10, 2025
Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis RiskNicholas A Marston, Brian A Bergmark, Veronica J Alexander, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The New England Journal of Medicine|April 8, 2024
Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular RiskBrian A Bergmark, Nicholas A Marston, Thomas A Prohaska, et al.
American Heart Journal|March 13, 2025
Olezarsen in patients with hypertriglyceridemia at high cardiovascular risk: Rationale and design of the Essence-TIMI 73b trialBrian A Bergmark, Nicholas A Marston, Thomas A Prohaska, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 13, 2016
Protective Role for B-1b B Cells and IgM in Obesity-Associated Inflammation, Glucose Intolerance, and Insulin ResistanceDaniel B Harmon, Prasad Srikakulapu, Jennifer L Kaplan, et al.
The New England Journal of Medicine|September 1, 2025
Targeting <i>APOC3</i> with Olezarsen in Moderate HypertriglyceridemiaBrian A Bergmark, Nicholas A Marston, Thomas A Prohaska, et al.
Nature|June 8, 2018
Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic miceXuchu Que, Ming-Yow Hung, Calvin Yeang, et al.
Nature|July 18, 2018
Publisher Correction: Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic miceXuchu Que, Ming-Yow Hung, Calvin Yeang, et al.
Circulation|March 30, 2026
Effect of APOC3 Inhibition with Olezarsen on Coronary Atherosclerosis: Essence-TIMI 73b Imaging StudyNicholas A Marston, Brian A Bergmark, Thomas A Prohaska, et al.
Molecular Cell|September 26, 2023
RANK ligand converts the NCoR/HDAC3 co-repressor to a PGC1β- and RNA-dependent co-activator of osteoclast gene expressionYohei Abe, Eric R Kofman, Maria Almeida, et al.
Immunity|March 21, 2025
Particle uptake by macrophages triggers bifurcated transcriptional pathways that differentially regulate inflammation and lysosomal gene expressionIsidoro Cobo, Jessica Murillo-Saich, Mohnish Alishala, et al.
The New England Journal of Medicine|November 10, 2025
Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis RiskNicholas A Marston, Brian A Bergmark, Veronica J Alexander, et al.
Pageof 2